SCHEMBL4564289

SCHEMBL4564289

CCC(O)(c1cccc(Br)c1)c1ccccc1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 3/20 0.39
GRIK1 P39086 2/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MPO P05164 1/20 0.36
KIF11 P52732 1/20 0.36
ABL1 P00519 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
RIN1 Q13671 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
RIPK1 Q13546 1/20 0.36
GAA P10253 1/20 0.35
NPC1 O15118 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RAB9A P51151 2/20 0.35
SORT1 Q99523 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
AKR1C3 P42330 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9906148 0.81 KIF11 (0.44) MEN1KMT2AKIF11RIPK1GAA
SCHEMBL7809644 0.70 SMN1; SMN2 (0.47) MEN1KMT2ASMN1; SMN2
SCHEMBL27641846 0.70 SMN1; SMN2 (0.41) MEN1KMT2ASMN1; SMN2
SCHEMBL1525128 0.69 CA1 (0.41) MEN1KMT2AKIF11RIPK1GAA
SCHEMBL11699226 0.69 ALDH1A1 (0.50) TAS2R14MEN1KMT2AMAPTTSHR
SCHEMBL31320998 0.69 RIPK1 (0.44) MEN1KMT2AKIF11RIPK1GAA
SCHEMBL19319661 0.69 KDM4E (0.43) GRIK1MEN1KMT2AMPOMAPT
SCHEMBL8625772 0.68 ALDH1A1 (0.41) TAS2R14KMT2AMAPTTDP1SMN1; SMN2
SCHEMBL5898552 0.68 SCN5A (0.48) MEN1KMT2AKIF11MAPTRIPK1
SCHEMBL14234964 0.68 ALDH1A1 (0.48) MEN1KMT2AMAPTTSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2109615-A1 SUBSTITUTED PYRANO [2, 3 - B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS Merck & Co., Inc. (US) 2009-10-21 EP disclosed
EP-2094664-A2 A NEW PROCESS FOR THE PREPARATION OF MONTELUKAST KRKA, tovarna zdravil, d.d., Novo mesto (SI) 2009-09-02 EP disclosed
WO-2008094476-A1 SUBSTITUTED PYRANO [2, 3 - B] PYRIDINE DERIVATIVES AS CANNABINOID -1 RECEPTOR MODULATORS MERCK & CO., INC. (US) 2008-08-07 WO disclosed
WO-2008049922-A2 A NEW PROCESS FOR THE PREPARATION OF MONTELUKAST KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) 2008-05-02 WO disclosed